Setting the record straight: The office
β
Alice M. Sapienza
π
Article
π
1993
π
John Wiley and Sons
π
English
β 617 KB
The U.S. Office of Technology Assessment (OTA) report on pharmaceutical research and development ( R & D ) s o s t s , risks, rewards-has generated a range of often heated responses, both for and against the industry. The purpose of this commentary is t o clarify two points of confusion that repeate